BALANCE SHEETS - USD ($)	Dec. 31, 2016	Sep. 30, 2016
CURRENT ASSETS:
Cash and cash equivalents	$ 2,386,673	$ 2,917,996
Receivables	4,128	394,515
Prepaid expenses	866,987	981,677
Deposits - current portion	154,995	154,995
Inventory used for R&D and manufacturing	694,504	1,008,642
Total current assets	4,107,287	5,457,825
PROPERTY AND EQUIPMENT, net	17,225,860	17,350,836
PATENT COSTS, net	247,267	256,547
DEPOSITS	1,670,917	1,820,917
TOTAL ASSETS	23,251,331	24,886,125
CURRENT LIABILITIES:
Accounts payable	2,741,353	3,091,512
Accrued expenses	319,476	378,672
Due to employees	476,413	538,278
Derivative instruments, current portion	249,157	0
Other current liabilities	7,203	3,310
Total current liabilities	3,793,602	4,011,772
Derivative instruments - net of current portion	1,533,549	8,394,934
Lease liability	13,062,236	13,011,023
Deferred revenue	125,000	125,000
Other Liabilities	42,447	22,609
Total liabilities	18,556,834	25,565,338
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized, 7,633,803 and 6,235,035 shares issued and outstanding at December 31, 2016 and September 30, 2016, respectively	76,338	62,350
Additional paid-in capital	286,488,128	284,649,559
Accumulated deficit	(281,869,969)	(285,391,122)
Total stockholders' equity (deficit)	4,694,497	(679,213)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 23,251,331	$ 24,886,125